Weekly Policy Update: Legislative Session Comes to a Close - Final Week Round Up

The legislative session continued for a third week with a wave of controversial bills, including the introduction of House Bill 1420, which would eliminate critical tax breaks and relief for Colorado...

Learn More

New Data Demonstrates Life Sciences Ecosystem Growth, Impact in Colorado

Numbers Signal Steady Jobs, Salary, and Funding Gains DENVER – Colorado BioScience Association shares newly released employment and federal funding data on life sciences in Colorado, demonstrating eco...

Learn More

CBSA Board Welcomes AGC Biologics

Colorado BioScience Association warmly welcomes AGC Biologics to our state. Last week, the global CDMO announced it will invest $100 million in a large-scale biopharmaceutical manufacturing facility i...

Learn More

Weekly Policy Update: Congress Passes New Law Creating More Flexibility in the Paycheck Protection Program

On Friday, President Trump signed into law the Paycheck Protection Program Flexibility Act. The new law addresses many concerns raised by the small business community about the Paycheck Protection Pro...

Learn More

CBSA Hosts Virtual Roundtable with Congressman Ed Perlmutter

This week, CBSA hosted a roundtable with Congressman Ed Perlmutter, who represents Colorado’s seventh Congressional district. It was a great opportunity for members of our community to ask questi...

Learn More

AGC Biologics Chooses Colorado, Invests $100 Million in Boulder Facility

On behalf of Colorado’s life sciences community, CBSA is pleased to welcome Global CDMO AGC Biologics to our state. The company invested $100 million in a 300,000-square-foot facility in Boulder and w...

Learn More

Congratulations, Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

AveXis, a Novartis Company, agrees to contribute the use of its gene therapy manufacturing expertise to help produce and scale novel vaccine that uses adeno-associated virus (AAV) vector for clinical...

Learn More

Weekly Policy Update: State Legislature Resumes - Week One Round Up

On May 26, the Colorado state legislature resumed the 2020 session with a condensed list of bills. Here’s a quick recap of key bills that were heard this week. House Bill 1195, Consumer Digital Repair...

Learn More

Innovative Industries Internship Program Update

Since last fall, CBSA has been advocating for an extension of the Innovative Industries Internship Program, which is set to expire July 1 of this year. The program incentivizes employers to find, hire...

Learn More